25 October 2022
Pictured, from left: GSK Australia Graduate Researchers from the 2022 cohort – Dr Neelam Shah, Dr Upasna Varma, Dr Francisco Sadras, Dr Anushi Rajapaksa, Dr Anitha Yates and Dr Madeline Nicholson – with Patrick Desbiens (third from the right) Senior Vice-President and General Manager, GSK Australia and New Zealand.
The GSK Australia Graduate Researcher Program is an Australian government funded, industry-hosted initiative developed to help bridge the skills gap between academia and the pharmaceutical industry. The program aims to provide participants with a diverse range of development opportunities, hands-on experiences, and exposure, with a view to improving Australia’s success, capacity, and capability in terms of the translation and commercialisation of health and medical research.
Developed by multinational pharmaceutical GSK Australia, with support from MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative – funded through the Australian Government’s Medical Research Future Fund (MRFF), the program gives PhD postgraduates a 12-month industry placement. They are assigned to lead on core projects in areas such as early product development, medical affairs and regulatory affairs – building industry capabilities of Australian researchers and establishing their career foundations.
Applications for the 2023 GSK Australia Researcher Program open in early November, and this is the third year of the REDI-supported program.
The paid 12-month work placement program is available to biomedical/science PhD graduates or postdoctoral researchers. To be eligible, students need to have their PhD conferred at the time of application.
GSK Australia is now finalising roles for next year’s program – January to December 2023 – and commences recruitment in early November. If you are eligible for and interested in this program, you can submit an expression of interest via the link below:
GSK Australia Graduate Researcher Program – Application for 2023 – this allows GSK to notify you when applications open for their 2023 intake.
Eligibility requirements for GSK Australia Graduate Researcher Program:
- You must be a PhD graduate or postdoc researcher (PhD must be conferred at the time of application).
- You must be available to work full-time from January 2023 to December 2023.
- You must be a citizen or permanent resident of New Zealand or Australia OR be able to provide proof that you have valid working rights that enable you to work full time for the 12-month period of the program.
To find out more about this Graduate Researcher Program and the experience it offers, hear from one of GSK Australia’s Graduate Researcher alumni, Abraham Daniel, a graduate researcher selected for the first cohort in 2020, and his Manager Dr Lachlan Gray, a Medical Manager at ViiV Healthcare Australia – interviewed on the MTPConnect Podcast here. ViiV Healthcare is an independent global specialist HIV company operating as a joint venture between GSK, Pfizer and Shionogi.
GSK is now a fully focussed biopharma company with a new purpose: to unite science, technology and talent to get ahead of disease together. The multinational pharmaceutical company aims to impact the health of 2.5 billion people over the next 10 years. At the centre of this is GSK’s R&D focus on the science of the immune system, human genetics and advanced technologies, and its world-leading capabilities in vaccine and medicines development.
“Culture at GSK is something we all own. It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive.” GSK
For more information: GSK Australia.
MTPConnect would like to thank GSK Australia for providing the original information and photo for this news story.